Skip to main content

Advertisement

SpringerLink
Log in

Pain in Patients with Pancreatic Cancer: Prevalence, Mechanisms, Management and Future Developments

  • Review
  • Published:
Digestive Diseases and Sciences Aims and scope Submit manuscript

Abstract

Pain affects approximately 80% of patients with pancreatic cancer, with half requiring strong opioid analgesia, namely: morphine-based drugs on step three of the WHO analgesic ladder (as opposed to the weak opioids: codeine and tramadol). The presence of pain is associated with reduced survival. This article reviews the literature regarding pain: prevalence, mechanisms, pharmacological, and endoscopic treatments and identifies areas for research to develop individualized patient pain management pathways. The online literature review was conducted through: PubMed, Clinical Key, Uptodate, and NICE Evidence. There are two principal mechanisms for pain: pancreatic duct obstruction and pancreatic neuropathy which, respectively, activate mechanical and chemical nociceptors. In pancreatic neuropathy, several histological, molecular, and immunological changes occur which correlate with pain including: transient receptor potential cation channel activation and mast cell infiltration. Current pain management is empirical rather etiology-based and is informed by the WHO analgesic ladder for first-line therapies, and then endoscopic ultrasound-guided celiac plexus neurolysis (EUS-CPN) in patients with resistant pain. For EUS-CPN, there is only one clinical trial reporting a benefit, which has limited generalizability. Case series report pancreatic duct stenting gives effective analgesia, but there are no clinical trials. Progress in understanding the mechanisms for pain and when this occurs in the natural history, together with assessing new therapies both pharmacological and endoscopic, will enable individualized care and may improve patients’ quality of life and survival.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Similar content being viewed by others

References

  1. Globocan. Estimated cancer incidence, mortality and prevalence worldwide. 2012. http://globocan.iarc.fr/Pages/fact_sheets_population.aspx.

  2. Pancreatic Cancer Research UK. 2014. http://www.cancerresearchuk.org/health-professional/cancer-statistics/statistics-by-cancer-type/pancreatic-cancer/incidence#ref-0.

  3. Freelove R, Waling AD. Pancreatic cancer: diagnosis and management. Am Fam Physician. 2006;73:485–492.

    PubMed  Google Scholar 

  4. Moore JC, Adler DG. Celiac plexus neurolysis for pain relief in pancreatic cancer. Support Oncol. 2009;7:83–87.

    Google Scholar 

  5. Moningi S, Walker AJ, Hsu CC, et al. Correlation of clinical stage and performance status with quality of life in patients seen in a pancreas multidisciplinary clinic. J Oncol Pract. 2014;112:e216–e221.

    Google Scholar 

  6. Müller F, Köninger M, Wente H, Ceyhan B, Kleeff B. Factors influencing survival after bypass procedures in patients with advanced pancreatic adenocarcinomas. Am J Surg. 2008;195:221–228.

    Article  PubMed  Google Scholar 

  7. Barreto SG, Saccone GTP. Pancreatic nociception—revisiting the physiology and pathophysiology. Pancreatology. 2012;12:104–112.

    Article  CAS  PubMed  Google Scholar 

  8. Sharaiha R, Widmer J, Kahaleh K. Palliation of pancreatic ductal obstruction in pancreatic cancer. Gastrointest Endosc Clin N Am. 2013;23:917–923.

    Article  PubMed  Google Scholar 

  9. Wehrmann T, Riphaus F, Martchenko S. Endoscopic pancreatic duct stenting for relief of pancreatic cancer pain. Eur J Gastroenterol Hepatol. 2005;17:1395–1400.

    Article  PubMed  Google Scholar 

  10. Costamagna A, Palladino R, Mutignani M. Endoscopic pancreatic stenting in pancreatic cancer. Can J Gastroenterol. 1999;13:481–487.

    Article  CAS  PubMed  Google Scholar 

  11. Ceyhan GO, Bergmann F, Kadihasanoglu M, et al. Pancreatic neuropathy and neuropathic pain—a comprehensive pathomorphological study of 546 cases. Gastroenterology. 2009;136:177–186.

    Article  PubMed  Google Scholar 

  12. di Mola FF, di Sebastiano P. Pain and pain generation in pancreatic cancer. Langenbecks Arch Surg. 2008;393:919–922.

    Article  PubMed  Google Scholar 

  13. Hartel M, Di Mola FF, Selvaggi F, et al. Vanilloids in pancreatic cancer: potential for chemotherapy and pain management. Gut. 2006;55:519–528.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  14. Demir IE, Schorn S, Schremmer-Danninger E, et al. Perineural mast cells are specifically enriched in pancreatic neuritis and neuropathic pain in pancreatic cancer and chronic pancreatitis. PLoS One. 2013;8:60529.

    Article  Google Scholar 

  15. Hameed M, Hameed H, Erdek M. Pain management in pancreatic cancer. Cancers (Basel). 2010;3:43–60.

    Article  Google Scholar 

  16. Esin E, Yalcin S. Neuropathic cancer pain: What we are dealing with? How to manage it? Oncol Targets Therapy. 2014;17:599–618.

    Google Scholar 

  17. Levy J, Wiersema J. Endoscopic ultrasound-guided celiac plexus and ganglia interventions. UptoDate. 2010. http://www.uptodate.com/contents/endoscopic-ultrasound-guided-celiac-plexus-and-ganglia-interventions.

  18. Luz L, Al-Haddad M, DeWitt JA. EUS-guided celiac plexus interventions in pancreatic cancer pain: an update and controversies for the endosonographer. Endosc Ultrasound. 2014;3:213–220.

    Article  PubMed  PubMed Central  Google Scholar 

  19. Nagels W, Pease N, Bekkering G, Cools F, Dobbels P. celiac plexus neurolysis for abdominal cancer pain: a systematic review. Pain Med Oxf J. 2013;14:1140–1163.

    Article  Google Scholar 

  20. Kambadakone A, Thabet A, Gervais DA, Mueller PR, Arellano RS. CT-guided celiac plexus neurolysis: a review of anatomy, indications, technique, and tips for successful treatment. Radiographics. 2011;31:1599–1621.

    Article  PubMed  Google Scholar 

  21. Sahai AV, Lemelin V, Lam E, Paquin SC. Central vs. bilateral endoscopic ultrasound-guided celiac plexus block or neurolysis: a comparative study of short-term effectiveness. Am J Gastroenterol. 2009;104:326–329.

    Article  PubMed  Google Scholar 

  22. Sakamoto H, Kitano M, Kamata K, et al. EUS-guided broad plexus neurolysis over the superior mesenteric artery using a 25-gauge needle. Am J Gastroenterol. 2010;105:2599–2606.

    Article  PubMed  Google Scholar 

  23. Mittal KM. Pearls & oysters: acute spinal cord infarction following endoscopic ultrasound-guided celiac plexus neurolysis. Neurology. 2012;78:57–59.

    Article  Google Scholar 

  24. Fujii L, Clain JE, Morris JM, Levy MJ. Anterior spinal cord infarction with permanent paralysis following endoscopic ultrasound celiac plexus neurolysis. Endoscopy. 2012;44:255–256.

    Article  Google Scholar 

  25. Wyse JM, Carone M, Paquin SC, Usatii M, Sahai AV. Randomized, double-blind, controlled trial of early endoscopic ultrasound-guided celiac plexus neurolysis to prevent pain progression in patients with newly diagnosed, painful, inoperable pancreatic cancer. J Clin Oncol. 2011;29:3541–3546.

    Article  PubMed  Google Scholar 

  26. Puli SR, Reddy JBK, et al. EUS-guided celiac plexus neurolysis for pain due to chronic pancreatitis or pancreatic cancer pain: a meta-analysis and systematic review. Dig Dis Sci. 2009;54:2330–2337.

    Article  PubMed  Google Scholar 

  27. Kaufman M, Singh G, Das S, et al. Efficacy of endoscopic ultrasound-guided celiac plexus block and celiac plexus neurolysis for managing abdominal pain associated with chronic pancreatitis and pancreatic cancer. J Clin Gastroenterol. 2010;44:127–134.

    Article  PubMed  Google Scholar 

  28. Iwata K, Yasuda I, Enya M, et al. Predictive factors for pain relief after endoscopic ultrasound-guided celiac plexus neurolysis. Dig Endosc. 2011;23:140–145.

    Article  PubMed  Google Scholar 

  29. Ascunce G, Ribeiro A, Reis I, et al. EUS visualization and direct celiac ganglia neurolysis predicts better pain relief in patients with pancreatic malignancy. Gastrointest Endosc. 2011;73:267–274.

    Article  PubMed  Google Scholar 

  30. Kristensen A, Vagnildhaug OM, Grønberg BH, Kaasa S, Laird B, Solheim TS. Does chemotherapy improve health-related quality of life in advanced pancreatic cancer? A systematic review. J Oncol Haematol. 2016;99:286–298.

    CAS  Google Scholar 

  31. Gunaratnam NT, Sarma AV, Norton ID, Wiersema MJ. A prospective study of EUS-guided celiac plexus neurolysis for pancreatic cancer pain. Gastrointest Endosc. 2001;54:316–324.

    Article  CAS  PubMed  Google Scholar 

  32. Catalano MF, Ahmed U, Chauhan SS, Patel SN, Geenen JE. Celiac plexus neurolysis (CPN) in the treatment of refractory pain of pancreatic cancer (PCA): site specific response to therapy. Gastrointest Endosc. 2005;61:AB273.

    Google Scholar 

  33. Wiersema MJ, Wiersema LM. Endosonography-guided celiac plexus neurolysis. Gastrointest Endosc. 1996;44:656–662.

    Article  CAS  PubMed  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Norwich Medical School, University of East Anglia, Bob Champion Research Center, Norwich Research Park, Norfolk, NR4 7TJ, UK

    Andreas I. Koulouris, Paul Banim & Andrew R. Hart

  2. Norfolk and Norwich University Hospital, Gastroenterology, Colney Lane, Norwich, NR4 7UY, UK

    Andreas I. Koulouris & Andrew R. Hart

  3. James Paget University Hospital, Lowestoft Rd, Gorleston-on-Sea, Great Yarmouth, NR31 6LA, UK

    Paul Banim

Authors
  1. Andreas I. Koulouris
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Paul Banim
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. Andrew R. Hart
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Andreas I. Koulouris.

Ethics declarations

Conflict of interest

The authors have no conflicts of interest to disclose.

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Koulouris, A.I., Banim, P. & Hart, A.R. Pain in Patients with Pancreatic Cancer: Prevalence, Mechanisms, Management and Future Developments. Dig Dis Sci 62, 861–870 (2017). https://doi.org/10.1007/s10620-017-4488-z

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s10620-017-4488-z

Keywords

Search

Navigation